Circulating Tumor DNA as a Biomarker of Progression in Colorectal Cancer - Episode 8

Between the Lines™ Podcast: ctDNA as a Biomarker of Progression in Colorectal Cancer


Liliana Bustamante, MD, and Richard Kim, MD, discuss circulating tumor DNA as a potential prognostic biomarker for patients with colorectal cancer.

As part of the Between the Lines™ video series, CancerNetwork® spoke with Liliana Bustamante, MD, of Florida Cancer Specialists in Fort Myers, Florida, and Richard Kim, MD, service chief of Medical Gastrointestinal Oncology and senior member in the Gastrointestinal Oncology Department at the Moffitt Cancer Center in Tampa, Florida, about the prognostic potential of circulating tumor DNA (ctDNA) as a biomarker for patients with oligometastatic colorectal cancer.

In the video series, Bustamante and Kim discussed the following:

To watch more videos in the CancerNetwork® Between the Lines™ series, visit

Don’t forget to subscribe to the “Oncology Peer Review On-The-Go” podcast on Apple Podcasts, Spotify, or anywhere podcasts are available.